Original Research
Accepted on 14 Nov 2025
Pharmacovigilance Study on Neurological Adverse Reactions of Proteasome Inhibitors in the FDA Adverse Event Reporting System
in Pharmacoepidemiology
Frontiers in Pharmacology
Type at least 3 characters
553 articles
Original Research
Accepted on 14 Nov 2025
Disproportionality Analysis of Biliary Adverse Events Associated with Fibrates Using the JADER and FAERS Databases
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Published on 13 Nov 2025
Evaluation of standard use of intravenous infusion in 25 general hospitals in Shanxi province based on factor analysis and cluster analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1708461
- 246 views
Original Research
Accepted on 12 Nov 2025
Comparative Safety Profile of Levofloxacin versus Moxifloxacin in First-Line Tuberculosis Therapy: A Pharmacovigilance Study of the FAERS Database
in Pharmacoepidemiology
Frontiers in Pharmacology
- 140 views
Original Research
Published on 12 Nov 2025
Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1687698
- 1,506 views
Original Research
Published on 11 Nov 2025
HPV vaccine-related thyroid adverse events: temporal patterns and reporting trends
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1664697
- 1,528 views
Original Research
Published on 11 Nov 2025
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for etrasimod
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1693090
- 295 views
Original Research
Accepted on 10 Nov 2025
Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Accepted on 10 Nov 2025
Disproportionality Analysis of Taste Disorders Using the FDA Adverse Event Reporting System and Japanese Adverse Drug Event Report Databases
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Published on 10 Nov 2025
The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1702875
- 410 views
Original Research
Published on 10 Nov 2025
The correlation between the use of ondansetron and mortality in sepsis associated encephalopathy patients: a retrospective ICU cohort study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1712328
- 494 views
Original Research
Published on 10 Nov 2025
Disproportionality evaluation of adverse effects and suicide/self-injury risk factors associated with vortioxetine: a large-scale pharmacovigilance study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1689634
- 350 views
Original Research
Accepted on 06 Nov 2025
Pharmacovigilance Signal Detection of Psychiatric Adverse Events Induced by Third-Generation Antiepileptic Drugs in Children
in Pharmacoepidemiology
Frontiers in Pharmacology
Original Research
Accepted on 06 Nov 2025
Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA adverse event reporting system database and a review of published cases
in Pharmacoepidemiology
Frontiers in Pharmacology
- 127 views
Original Research
Accepted on 04 Nov 2025
Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030
in Pharmacoepidemiology
Frontiers in Pharmacology
- 126 views
Original Research
Accepted on 03 Nov 2025
Knowledge, Attitudes, and Practices of Pharmacists Toward Over-the-Counter Medication Use in Iraq: A Nationwide Cross-Sectional Study
in Pharmacoepidemiology
Frontiers in Pharmacology
- 106 views